Coordinated molecular cross-talk between staphylococcus aureus, endothelial cells and platelets in bloodstream infection

Pathogens

Volumn 4, Issue 4, 2015, Pages 869-882

  Garciarena, Carolina D ^a   McHale, Tony M ^a   Watkin, Rebecca L ^a   Kerrigan, Steven W ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Endothelial cells; Infective endocarditis; Platelets; Sepsis; Staphylococcus aureus

Indexed keywords

BACTERIAL ENDOCARDITIS; BLOODSTREAM INFECTION; ENDOTHELIUM CELL; MOLECULAR INTERACTION; NONHUMAN; PHAGOCYTE; PHOSPHORYLATION; PROTEIN EXPRESSION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 84977460194     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens4040869     Document Type: Review

References (77)

1. Foster, T. J. Colonization and infection of the human host by staphylococci: Adhesion, survival and immune evasion. Vet. Dermatol. 2009, 20, 456-470.
2. Lowy, F. D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339, 520-532.
3. Cahill, T. J.; Prendergast, B. D. Infective endocarditis. Lancet 2015, doi: 10. 1016/S0140-6736(15)00067-7.
4. Murdoch, D. R.; Corey, G. R.; Hoen, B.; Miró, J. M.; Fowler, V. G., Jr; Bayer, A. S.;. Karchmer, A. W.; Olaison, L.; Pappas, P. A.; Moreillon, P.; et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern. Med. 2009, 169, 463-473.
5. Selton-Suty, C.; Celard, M.; Le Moing, V.; Doco-Lecompte, T.; Chirouze, C.; Iung, B., Strady, C.; Revest, M.; Vandenesch, F.; Bouvet, A.; et al. Preeminence of Staphylococcus aureus in infective endocarditis: A 1-year population-based survey. Clin. Infect. Dis. 2012, 54, 1230-1239.
6. Kerrigan, S. W. The expanding field of platelet-bacterial interconnections. Platelets 2015, 26, 293-301.
7. Petersen, H.; Reynolds, K.; Newman, D. K.; Cox, D.; Jenkinson, H. F.; Newman, P. J.; Kerrigan, S. W. Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 2408-2415.
8. Alla, F.; Fowler, V. G., Jr; Sexton, D. J.; Corey, G. R.; Chu, V. H.; Wang, A.; Erpelding, M. L.; Durante-Mangoni, E.; Fernandez-Hidalgo, N.; et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. Clin. Infect. Dis. 2015, 60, 741-749.
9. Wang, A.; Athan, E.; Pappas, P. A.; Fowler, V. G., Jr.; Olaison, L.; Pare, C.; Almirante, B.; Munoz, P.; Rizzi, M.; Naber, C.; et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. J. Am. Med. Assoc. 2007, 297, 1354-1361.
10. Tong, S. Y.; Davis, J. S.; Eichenberger, E.; Holland, T. L.; Fowler, V. G., Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015, 28, 603-661.
11. Sidhu, P.; O'Kane, H.; Ali, N.; Gladstone, D. J.; Sarsam, M. A.; Campalani, G.; MacGowan, S. W. Mechanical or bioprosthetic valves in the elderly: A 20-year comparison. Ann. Thorac. Surg. 2001, 71, S257-S260.
12. Varstela, E. Personal follow-up of 100 aortic valve replacement patients for 1081 patient years. Ann. Chir. Gynaecol. 1998, 87, 205-212.
13. Widmer, E.; Que, Y. A.; Entenza, J. M.; Moreillon, P. New concepts in the pathophysiology of infective endocarditis. Curr. Infect. Dis. Rep. 2006, 8, 271-279.
14. Moreillon, P.; Que, Y. A. Infective endocarditis. Lancet 2004, 363, 139-149.
15. Kerrigan, S. W.; Clarke, N.; Loughman, A.; Meade, G.; Foster, T. J.; Cox, D. Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 335-340.
16. Yvorchuk, K. J.; Chan, K. L. Application of transthoracic and transesophageal echocardiography in the diagnosis and management of infective endocarditis. J. Am. Soc. Echocardiogr. 1994, 7, 294-308.
17. Prendergast, B. D.; Tornos, P. Surgery for infective endocarditis: Who and when? Circulation 2010, 121, 1141-1152.
18. Angus, D. C.; van der Poll, T. Severe sepsis and septic shock. N. Engl. J. Med. 2013, doi: 10. 1056/NEJMra1208623.
19. Glik, J.; M., Gazdzik, T.; Nowak, M. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis. Pol. J. Surg. 2012, 84, 6-16.
20. Li, J.; Carr, B.; Goyal, M.; Gaieski, D. F. Sepsis: The inflammatory foundation of pathophysiology and therapy. Hosp. Pract. (1995) 2011, 39, 99-112.
21. Lemichez, E.; Lecuit, M.; Nassif, X.; Bourdoulous, S. Breaking the wall: Targeting of the endothelium by pathogenic bacteria. Nat. Rev. Microbiol. 2010, 8, 93-104.
22. Mouncey, P. R.; Osborn, T. M.; Power, G. S.; Harrison, D. A.; Sadique, M. Z.; Grieve, R. D.; Jahan, R.; Harvey, S. E.; Bell, D.; Bion, J. F.; et al. Trial of early, goal-directed resuscitation for septic shock. N. Engl. J. Med. 2015, 372, 1301-111.
23. Dellinger, R. P.; Levy, M. M.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, S. M.; Sevransky, J. E.; Sprung, C. L.; Douglas, I. S.; Jaeschke, R.; et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock 2012. Intensive Care Med. 2013, 39, 165-228.
24. Buchan, C. A.; Bravi, A.; Seely, A. J. Variability analysis and the diagnosis, management, and treatment of sepsis. Curr. Infect. Dis. Rep. 2012, 14, 512-521.
25. Patti, J. M.; Allen, B. L.; McGavin, M. J.; Hook, M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 1994, 48, 585-617.
26. Edwards, A. M.; Bowden, M. G.; Brown, E. L.; Laabei, M.; Massey, R. C. Staphylococcus aureus extracellular adherence protein triggers TNFalpha release, promoting attachment to endothelial cells via protein A. PLoS One 2012, doi: 10. 1371/journal. pone. 0043046.
27. Miajlovic, H.; Zapotoczna, M.; Geoghegan, J. A.; Kerrigan, S. W.; Speziale, P.; Foster, T. J. Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets. Microbiology 2010, 156, 920-928.
28. Agerer, F.; Michel, A.; Ohlsen, K.; Hauck, C. R. Integrin-mediated invasion of Staphylococcus aureus into human cells requires Src family protein-tyrosine kinases. J. Biol. Chem. 2003, 278, 42524-42531.
29. Arvand, M.; Bhakdi, S.; Dahlback, B.; Preissner, K. T. Staphylococcus aureus alpha-toxin attack on human platelets promotes assembly of the prothrombinase complex. J. Biol. Chem. 1990, 265, 14377-14381.
30. Gould, K.; Ramirez-Ronda, C. H.; Holmes, R. K.; Sanford, J. P. Adherence of bacteria to heart valves in vitro. J. Clin. Invest. 1975, 56, 1364-1370.
31. Johnson, C. M.; Hancock, G. A.; Goulin, G. D. Specific binding of Staphylococcus aureus to cultured porcine cardiac valvular endothelial cells. J. Lab. Clin. Med. 1988, 112, 16-22.
32. Ogawa, S. K.; Yurberg, E. R.; Hatcher, V. B.; Levitt, M. A.; Lowy, F. D. Bacterial adherence to human endothelial cells in vitro. Infect. Immun. 1985, 50, 218-224.
33. Cheung, A. L.; Fischetti, V. A. The role of fibrinogen in staphylococcal adherence to catheters in vitro. J. Infect. Dis. 1990, 161, 1177-1186.
34. Cheung, A. L.; Krishnan, M.; Jaffe, E. A.; Fischetti, V. A. Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J. Clin. Invest. 1991, 87, 2236-2245.
35. Cheung, A. L.; Fischetti, V. A. The role of fibrinogen in mediating staphylococcal adherence to fibers. J. Surg. Res. 1991, 50, 150-155.
36. Cheung, A. L.; Koomey, J. M.; Lee, S.; Jaffe, E. A.; Fischetti, V. A. Recombinant human tumor necrosis factor alpha promotes adherence of Staphylococcus aureus to cultured human endothelial cells. Infect. Immun. 1991, 59, 3827-3831.
37. Shenkman, B.; Rubinstein, E.; Tamarin, I.; Dardik, R.; Savion, N.; Varon, D. Staphylococcus aureus adherence to thrombin-treated endothelial cells is mediated by fibrinogen but not by platelets. J. Lab. Clin. Med. 2000, 135, 43-51.
38. Tompkins, D. C.; Blackwell, L. J.; Hatcher, V. B.; Elliott, D. A.; O'Hagan-Sotsky, C.; Lowy, F. D. Staphylococcus aureus proteins that bind to human endothelial cells. Infect. Immun. 1992, 60, 965-969.
39. Cheung, A. L.; Koomey, J. M.; Butler, C. A.; Projan, S. J.; Fischetti, V. A. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. USA 1992, 89, 6462-6646.
40. Shenkman, B.; Varon, D.; Tamarin, I.; Dardik, R.; Peisachov, M.; Savion, N.; Rubinstein, E. Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions. J. Med. Microbiol. 2002, 51, 747-754.
41. Pohlmann-Dietze, P.; Ulrich, M.; Kiser, K. B.; Doring, G.; Lee, J. C.; Fournier, J. M.; Botzenhart, K.; Wolz, C. Adherence of Staphylococcus aureus to endothelial cells: Influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect. Immun. 2000, 68, 4865-4871.
42. Cedergren, L.; Andersson, R.; Jansson, B.; Uhlen, M.; Nilsson, B. Mutational analysis of the interaction between staphylococcal protein A and human IgG1. Protein Eng. 1993, 6, 441-448.
43. O'Seaghdha, M.; van Schooten, C. J.; Kerrigan, S. W.; Emsley, J.; Silverman, G. J.; Cox, D.; Lenting, P. J.; Foster, T. J. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. Federation Eur. Biochem. Soc. J. 2006, 273, 4831-4841.
44. Gomez, M. I.; O'Seaghdha, M.; Magargee, M.; Foster, T. J.; Prince, A. S. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J. Biol. Chem. 2006, 281, 20190-20196.
45. Gomez, M. I.; Seaghdha, M. O.; Prince, A. S. Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling. EMBO J. 2007, 26, 701-709.
46. Nguyen, T.; Ghebrehiwet, B.; Peerschke, E. I. Staphylococcus aureus protein A recognizes platelet gC1qR/p33: A novel mechanism for staphylococcal interactions with platelets. Infect. Immun. 2000, 68, 2061-2068.
47. Peerschke, E. I.; Ghebrehiwet, B. Human blood platelet gC1qR/p33. Immunol. Rev. 2001, 180, 56-64.
48. Claes, J.; Vanassche, T.; Peetermans, M.; Liesenborghs, L.; Vandenbriele, C.; Vanhoorelbeke, K.; Missiakas, D.; Schneewind, O.; Hoylaerts, M. F.; Heying, R.; et al. Adhesion of Staphylococcus aureus to the vessel wall under flow is mediated by von Willebrand factor-binding protein. Blood 2014, 124, 1669-1676.
49. Chavakis, T.; Hussain, M.; Kanse, S. M.; Peters, G.; Bretzel, R. G.; Flock, J. I.; Herrmann, M.; Preissner, K. T. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nat. Med. 2002, 8, 687-693.
50. Haggar, A.; Hussain, M.; Lonnies, H.; Herrmann, M.; Norrby-Teglund, A.; Flock, J. I. Extracellular adherence protein from Staphylococcus aureus enhances internalization into eukaryotic cells. Infect. Immun. 2003, 71, 2310-7231.
51. Lee, L. Y.; Miyamoto, Y. J.; McIntyre, B. W.; Hook, M., McCrea, K. W., McDevitt, D., and Brown, E. L. The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J. Clin. Invest. 2002, 110, 1461-1471.
52. Sinha, B.; Francois, P. P.; Nusse, O.; Foti, M.; Hartford, O. M.; Vaudaux, P.; Foster, T. J.; Lew, D. P.; Herrmann, M.; Krause, K. H. Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1. Cell. Microbiol. 1999, 1, 101-117.
53. Dziewanowska, K.; Patti, J. M.; Deobald, C. F.; Bayles, K. W.; Trumble, W. R.; Bohach, G. A. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect. Immun. 1999, 67, 4673-4678.
54. Ellington, J. K.; Elhofy, A.; Bost, K. L.; Hudson, M. C. Involvement of mitogen-activated protein kinase pathways in Staphylococcus aureus invasion of normal osteoblasts. Infect. Immun. 2001, 69, 5235-5242.
55. Fowler, T.; Johansson, S.; Wary, K. K.; Hook, M. Src kinase has a central role in in vitro cellular internalization of Staphylococcus aureus. Cell. Microbiol. 2003, 5, 417-426.
56. Conforti, G.; Zanetti, A.; Colella, S.; Abbadini, M.; Marchisio, P. C.; Pytela, R.; Giancotti, F.; Tarone, G.; Languino, L. R.; Dejana, E. Interaction of fibronectin with cultured human endothelial cells: Characterization of the specific receptor. Blood 1989, 73, 1576-1585.
57. Esen, M.; Schreiner, B.; Jendrossek, V.; Lang, F.; Fassbender, K.; Grassme, H.; Gulbins, E. Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 2001, 6, 431-439.
58. Menzies, B. E.; Kourteva, I. Staphylococcus aureus alpha-toxin induces apoptosis in endothelial cells. FEMS Immunol. Med. Microbiol. 2000, 29, 39-45.
59. Beekhuizen, H.; van de Gevel, J. S.; Olsson, B.; van Benten, I. J.; van Furth, R. Infection of human vascular endothelial cells with Staphylococcus aureus induces hyperadhesiveness for human monocytes and granulocytes. J. Immunol. 1997, 158, 774-782.
60. Moreland, J. G.; Bailey, G.; Nauseef, W. M.; Weiss, J. P. Organism-specific neutrophil-endothelial cell interactions in response to Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus. J. Immunol. 2004, 172, 426-432.
61. Powers, M. E.; Kim, H. K.; Wang, Y.; Bubeck Wardenburg, J. ADAM10 mediates vascular injury induced by Staphylococcus aureus alpha-hemolysin. J. Infect. Dis. 2012, 206, 352-356.
62. Wilke, G. A.; Wardenburg, J. B. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc. Natl. Acad. Sci. USA 2010, 107, 13473-13478.
63. Aird, W. C. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ. Res. 2007, 100, 158-173.
64. Aird, W. C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 2007, 100, 174-190.
65. Siegel, I.; Cohen, S. Action of Staphylococcal Toxin on Human Platelets. J. Infect. Dis. 1964, 114, 488-502.
66. Sheu, J. R.; Hsiao, G.; Lee, C.; Chang, W.; Lee, L. W.; Su, C. H.; Lin, C. H. Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway. Thromb. Res. 2000, 99, 249-258.
67. Sheu, J. R.; Lee, C. R.; Lin, C. H.; Hsiao, G.; Ko, W. C.; Chen, Y. C.; Yen, M. H. Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. Thromb. Haemost. 2000, 83, 777-784.
68. Waller, A. K.; Sage, T.; Kumar, C.; Carr, T.; Gibbins, J. M.; Clarke, S. R. Staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the Paf receptor. J. Infect. Dis. 2013, 208, 2046-2057.
69. Powers, M. E.; Becker, R. E.; Sailer, A.; Turner, J. R.; Bubeck Wardenburg, J. Synergistic Action of Staphylococcus aureus alpha-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis. Cell Host Microbe 2015, 17, 775-787.
70. Hawiger, J.; Steckley, S.; Hammond, D.; Cheng, C.; Timmons, S.; Glick, A. D.; Des Prez, R. M. Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor. J. Clin. Invest. 1979, 64, 931-937.
71. Andrews, R. K.; Gardiner, E. E.; Shen, Y.; Berndt, M. C. Structure-activity relationships of snake toxins targeting platelet receptors, glycoprotein Ib-IX-V and glycoprotein VI. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2003, 1, 143-149.
72. Siboo, I. R.; Cheung, A. L.; Bayer, A. S.; Sullam, P. M. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect. Immun. 2001, 69, 3120-3127.
73. O'Brien, L.; Kerrigan, S. W.; Kaw, G.; Hogan, M.; Penades, J.; Litt, D.; Fitzgerald, D. J.; Foster, T. J.; Cox, D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: Roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol. Microbiol. 2002, 44, 1033-1044.
74. Loughman, A.; Fitzgerald, J. R.; Brennan, M. P.; Higgins, J.; Downer, R.; Cox, D.; Foster, T. J. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol. Microbiol. 2005, 57, 804-818.
75. Fitzgerald, J. R.; Loughman, A.; Keane, F.; Brennan, M.; Knobel, M.; Higgins, J.; Visai, L.; Speziale, P.; Cox, D.; Foster, T. J. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Mol. Microbiol. 2006, 59, 212-230.
76. Siboo, I. R.; Chambers, H. F.; Sullam, P. M. Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect. Immun. 2005, 73, 2273-2280.
77. Pawar, P.; Shin, P. K.; Mousa, S. A.; Ross, J. M.; Konstantopoulos, K. Fluid shear regulates the kinetics and receptor specificity of Staphylococcus aureus binding to activated platelets. J. Immunol. 2004, 173, 1258-1265.